<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01653821</url>
  </required_header>
  <id_info>
    <org_study_id>FIM-WROCPL-CORIDEA</org_study_id>
    <nct_id>NCT01653821</nct_id>
  </id_info>
  <brief_title>Surgical Removal of Carotid Body in Patients With Systolic Heart Failure</brief_title>
  <acronym>FIM</acronym>
  <official_title>Surgical Removal of Carotid Body in Patients With Systolic Heart Failure.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Noblewell</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Noblewell</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to determine safety, tolerability and feasibility of unilateral and
      bilateral carotid body excision in patients with systolic heart failure and peripheral
      chemoreceptor hypersensitivity.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2012</start_date>
  <completion_date type="Actual">November 2013</completion_date>
  <primary_completion_date type="Actual">November 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Peripheral chemosensitivity</measure>
    <time_frame>4 weeks</time_frame>
    <description>Ventilatory response to hypoxia using transient inhalation of nitrogen.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Systolic Heart Failure</condition>
  <condition>Peripheral Chemoreceptor Hypersensitivity</condition>
  <arm_group>
    <arm_group_label>Carotid body excision</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients undergoing unilateral or bilateral removal of carotid body.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Carotid body excision</intervention_name>
    <arm_group_label>Carotid body excision</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  History of heart failure class II-III according to NYHA within at least 6 months prior
             to inclusion

          -  Stable clinical state within at least 4 weeks prior to inclusion

          -  Subject &gt;= 18 years old

          -  Left ventricular ejection fraction ≤ 45% evaluated by transthoracic echocardiography
             (Simpson's method)

          -  Carotid body present in computer cervical angiotomography

          -  History of exacerbated peripheral chemoreceptor sensitivity determined as
             &gt;0.6L/min/%SpO2

          -  Able and willing to give written informed consent

        Exclusion Criteria:

          -  Unstable angina pectoris, coronary attack, coronary revascularization, exacerbation of
             heart-failure requiring hospitalization, clinically significant infection, surgery
             under general anesthesia within 3 months prior to inclusion

          -  History of stroke, transient ischemic attack (TIA), or clinically significant chronic
             neurological disorder

          -  History of heart transplant

          -  Pregnancy or anticipation of pregnancy

          -  Hemodialysis or peritoneal dialysis patients

          -  Obstructive carotid atherosclerotic disease with &gt;50% stenosis

          -  Severe sleep apnea syndrome diagnosed in PSG

          -  COPD stage III and IV according to GOLD 2007

          -  Unable to perform the spiroergometric assessment

          -  Any significant anomaly in additional investigation which may increase the risk of
             study procedure
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Centrum Chorób Serca - Klinika Kardiologii, 4. Wojskowy Szpital Kliniczny</name>
      <address>
        <city>Wroclaw</city>
        <zip>50-981</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <link>
    <url>http://onlinelibrary.wiley.com/doi/10.1002/ejhf.641/abstract</url>
    <description>Carotid body resection for sympathetic modulation in systolic heart failure: results from first-in-man study</description>
  </link>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 26, 2012</study_first_submitted>
  <study_first_submitted_qc>July 27, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 31, 2012</study_first_posted>
  <last_update_submitted>October 14, 2016</last_update_submitted>
  <last_update_submitted_qc>October 14, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 18, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>carotid body</keyword>
  <keyword>heart failure</keyword>
  <keyword>chemoreceptor</keyword>
  <keyword>hypersensitivity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Hypersensitivity</mesh_term>
    <mesh_term>Heart Failure, Systolic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

